comparemela.com

Vir Biotechnology, Inc. today announced that Executive Vice President, and Chief Medical Officer, Phil Pang, M.D., Ph.D., has decided to leave the company at the end of March 2024 to spend more time...

Related Keywords

,Vir Biotechnology Inc ,Nasdaq ,Exchange Commission ,Vir Biotechnology ,Executive Vice President ,Chief Medical Officer ,Phil Pang ,Marianne De Backer ,Chief Executive ,Chief Medical ,Private Securities Litigation Reform Act ,Hepatitis Delta ,Markets ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.